Research Handbook on Intellectual Property and the Life Sciences
Show Less

Research Handbook on Intellectual Property and the Life Sciences

Edited by Duncan Matthews and Herbert Zech

Intellectual property (IP) is a key component of the life sciences, one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences raises new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry to provide in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines. The Research Handbook focuses on the relationship between IP and the life sciences in Europe and the United States, complemented by country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 9: Non-obvious plants

Mark D. Janis

Extract

The U.S. Patent and Trademark Office (PTO) has granted at least 9,000 utility patents directed to non-transgenic plant varieties. A substantial portion – over 4,000 – are directed to maize varieties, and nearly as many – over 3,000 – claim soybean varieties. Some varieties of wheat, canola, oats, barley, rye, sunflower, cotton, and selected other crop plants have also been the subject of utility patents, but the rate of patenting for these crops appears to be relatively light compared to that of corn and soybeans.It appears that roughly 90–95 per cent of U.S. utility patents that have been granted on non-transgenic plant varieties are of recent enough vintage that they are still in force as of the time of this writing, assuming that the maintenance fees have been paid.Little is known, at least publicly, about these patents as a group. There is virtually no academic writing,possibly only one reported case decision in an enforcement action,and only a tiny number of decisions reviewing PTO patentability determinations.Basic descriptive and normative questions – such as how the PTO is applying standards of patentability over the prior art to plant variety claims, and how the PTO should be doing so – have remained unexamined. This gap in the literature is significant not only for U.S. practice, but also for the course of European law, given the likelihood that patenting activity will increase significantly in respect to plant varieties in the coming years in the wake of the Tomato II and Broccoli II decisions.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.


Further information

or login to access all content.